Szilárd Kiss, MD, examines gene therapy as a hot topic both in eye care and health care in general. Dr. Kiss notes the less-than-stellar results of three recent gene therapy studies for wet AMD, and he highlights important factors to consider in implementing the technique. He also discusses several promising preclinical programs and identifies an ongoing clinical trial with potential.
gene therapy • Wet AMD